Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России; 2ФГБНУ Научный центр психического здоровья, Москва; 3Психиатрическая клиническая больница №1 им. Н.А.Алексеева Департамента здравоохранения г. Москвы; 4Ереванский государственный медицинский университет им. Мхитара Гераци, Грузия
Список исп. литературыСкрыть список 1. Доклады «Об итогах Всероссийской переписи населения 2010 года». Госкомстат России. 2010; http://www.gks.ru/free_doc/new_site/perepis2010/croc/perepis_itogi1612.htm 2. Краснов В.Н. Расстройства аффективного спектра. М.: Практическая медицина, 2011. 3. Смулевич А.Б. Депрессии в общемедицинской практике. М.: Берег, 2000; с. 160. 4. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: МИА, 2003; с. 432. 5. Смулевич А.Б., Андрющенко А.В., Романов Д.В., Захарова Н.В. Ремиссии при аффективных заболеваниях (эпидемиология, психопатология, клинический и социальный прогноз, вторичная профилактика). Журн. неврологии и психиатрии им. C.C.Корсакова. 2014; 114 (3): 4–13. 6. Akiskal HS, Jr. McKinney WT. Depressive disorders: toward a unified hypothesis. Science 1973; 182 (4107): 20–9. 7. Angst J. The history and concept of recurrent brief depression. Eur Arch Psychiat Clin Neurosci 1994; 244 (4): 171–3. 8. Ayuso-Mateos JL, Nuevo R, Verdes E et al. From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiat 2010; 196: 5: 365–71. 9. Bockting CL, Spinhoven P, Koeter MW et al. Depression Evaluation Longitudinal Therapy Assessment Study Group. Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study. J Clin Psychiat 2006; 67: 5: 747–55. 10. Bromet E, Andrade LH, Hwang I et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 2011; 9: 90. 11. Broadaty H, Luscombe G, Peisah C et al. 25-year longitudinal, comparison study of the outcome of depression. Psychological Med 2001; 31: 1347–59. 12. Cassano GB, Maggini C, Akiskal HS. Short-term, subchronic, and chronic sequelae of affective disorders. Psychiat Clin North Am 1983; 6 (1): 55–67. 13. Colman I, Naicker K, Zeng Y et al. Predictors of long-term prognosis of depression. CMAJ 2011; 183 (17): 1969–76. 14. Dombrovski AY, Frank E et al. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy? Depress Anxiety 2008; 25 (12): 1060–6. 15. Dombrovski AY et al. Residual symptoms and recurrence during maintenance treatment of late-life depression. J Affect Dis 2007; 103 (1–3): 77–82. 16. Eaton WW, Shao H, Nestadt G et al. Population-Based Study of First Onset and Chronicity in Major Depressive Disorder. Arch Gen Psychiat 2008; 65 (5): 513–20. 17. Faravelli C, Ambonetti A, Pallanti S, Pazzagli A. Depressive relapses and ncomplete recovery from index episode. Am J Psychiat 1986; 143: 888–91. 18. Fava GA et al. The concept of recovery in major depression. Psychological Med 2007; 37 (3): 307–17. 19. Frank E et al. Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder. Remission, Recovery, Relapse, and Recurrence Arch Gen. Psychiat 1991; 48: 851–5. 20. Israel JA. Remission in depression: definition and initial treatment approaches. J Psychopharmacol 2006; 20: 5–10. 21. Israel J. The Impact of Residual Symptoms in Major Depression. Pharmaceuticals 2010; 3: 2426–40. 22. Judd LL et al. A Prospective 12-Year Study of Subsyndromal and Syndromal Depressive Symptoms in Unipolar Major Depressive Disorders Arch Gen Psychiatry 1998; 55 (8): 694–700. 23. Judd LL, Paulus MJ, Schettler PJ et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiat 2000; 157 (9): 1501–4. 24. Hung ChI et al. Residual symptoms related to physical and panic symptoms at baseline predict remission of depression at follow-up psychopathology. Published online 2013. 25. Kanai T, Takeshi H et al. Time to recurrence after recovery from major depressive episodes and its predictors. Psychological Med 2003; 33 (5): 839–45. 26. Karp JF, Buysse DJ, Houck PR et al. Relationship of variability in residual symptoms with recurrence of major depressive disorder during maintenance treatment. Am J Psychiat 2004; 161: 1877–84. 27. Kessler RC, Demler O, Frank RG et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352 (24): 2515–23. 28. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiat 2003; 60: 929–37. 29. Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiat 2006; 63 (10): 1113–20. 30. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in men. Am J Psychiat 2006; 163 (1): 115–24. 31. Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiat 1999; 56: 322–7. 32. Kennedy N, Abbot R, Paykel ES. Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year follow-up study. Brit J Psychiat 2004; 184: 330–6. 33. Klein DN, Lewinsohn PM, Rohde P et al. Clinical features of major depressive disorder in adolescents and their relatives: impact on familial aggregation, implications for phenotype definition, and specificity of transmission. J Abnorm Psychol 2002; 111 (1): 98–106. 34. Kraepelin E. Manic-depressive insanity and paranoia. Edinburg 1921; p. 149–50. 35. Leonhard K. Classification of Endogenous Psychoses and their Differentiated Etiology. 2nd ed. H.Beckmann. NY/Wien: Springer-Verlag, 1999. 36. Lohoff FW. Overview of the genetics of major depressive disorder. Curr Psychiat Rep 2010; 12 (6): 539–46. 37. Manchia M, Cullis J, Turecki G et al. The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases. PloS One 2013; 8: e76295. 38. Mattisson C, Bogren M, Horstmann V et al. The long-term course of depressive disorders in the Lund by Study. Psychol Med 2007; 37 (6): 883–91. 39. Middeldorp CM, Sullivan PF, Wray NR et al. Suggestive linkage on chromosome 2, 8, and 17 for lifetime major depression. Am J Med Genet B Neuropsychiat Gen 2009; 150 B (3): 352–8. 40. Mondimore FM, Zandi PP, Mackinnon DF et al. Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees. Am J Psychiat 2006; 163: 1554–60. 41. Mueller TI, Leon AC, Keller MB, Solomon DA. Recurrence After Recovery From Major Depressive Disorder During 15 Years of Observational Follow-Up. Am J Psychiat 1999; 156: 1000–6. 42. Nierenberg AA, Husain MM, Trivedi MH et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report Psychological Med 2010; 40: (1): 41–50. 43. Paskind HA. Brief attacks of manic-depressive depression. Arch Neur Psychiat 1929; 22 (1): 123–34. 44. Patel V, Saxena S. Transforming lives, enhancing communities-innovations in global mental health. N Engl J Med 2014; 370 (6): 498–501. 45. Paykel ES, Ramana R, Cooper Z et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995; 25: 1171–80. 46. Paykel ES, Scott J, Teasdale JD et al. Prevention of relapse in residual depression by cognitive therapy. Arch Gen Psychiat 1999; 56: 829–35. 47. Romera I et al. Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiat 2013; 13: 51. 48. Slane JD, Burt SA, Klump KL. Genetic and environmental influences on disordered eating and depressive symptoms. Int J Eat Disord 2011; 44 (7): 605–11. 49. Steunenberg B, Beekman ATF, Deeg DJH, Kerkhof JFM. Personality predicts recurrence of late-life depression. J Affect Dis 2010; 123: 164–72. 50. Surtees PG, Barkley C. Future imperfect: the long-term outcome of depression. Brit J Psychiat 1994; 164: 327–41. 51. Thase ME, Simons AD, McGeary J et al. Relapse after cognitive behavior therapy of depression. Am J Psychiat 1992; 149: 1046–52. 52. Thase ME. Achieving Remission and Managing Relapse in Depression. J Clin Psychiat 2003; 64 (Suppl. 18): 3–7. 53. Londen van L, Molenaar RP, Goekoop JG et al. Three- to 5-year prospective follow-up of outcome in major depression. Psychol Med 1998; 28 (3): 731–5. 54. Wittchen HU, Jacobi F, Rehm J et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21 (9): 655–79. 55. Wray NR, Lee SH, Kendler KS. Impact of diagnostic misclassi-fication on estimation of genetic correlations using genome-wide genotypes. Eur J Hum Genet; 20: 668–74. 56. Zimmerman M et al. How should residual symptoms be defined in depressed patients who have remitted? Comprehens Psychiat 2013; 54: 91–6. 57. Zubenko GS, Zubenko WN, Spiker DG et al. Malignancy of recurrent, early-onset major depression: a family study. Am J Med Genet 2001; 105 (8): 690–9. 58. Kessler RC, Chiu WT, Demler O et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiat 2005; 62 (6): 617–27.